Small serine recombinases are markers for antiphage defense system discovery
PLOS Biology · 2026
DOI: 10.1371/journal.pbio.3003991 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2026. Verfasst von Shelby E Andersen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, University of Colorado School - Anschutz Medical Campus, School of Medicine, Aurora, Colorado, United Stat…. Hauptthemen laut MEDLINE: Bacteriophages, Recombinases, Bacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Renewed interest in phage therapy has highlighted a need to understand how bacteria subvert phage infection through antiphage defense systems. Traditionally, strategies to identify antiphage defense systems lack throughput or have limitations for bacterial species where antiphage defense systems are understudied. Herein, we developed a bioinformatic pipeline that uses a small serine recombinase to identify known and unknown antiphage defense systems. Using this approach to query reference genomes and metagenomes, we show that small serine recombinase genes are genetically linked to antiphage defense systems and serve as bait for finding these systems across diverse bacterial phyla. Using co-transcription predictions and statistical analysis of protein domain abundances, we experimentally validated our bioinformatic approach by discovering that KAP P-loop NTPases are fused to putative antiphage domains and reinforce prokaryotic Schlafen proteins as a new class of antiphage defense. Our work shows that small serine recombinases are a reliable genetic marker for the discovery of antiphage defenses across diverse bacterial phyla.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, University of Colorado School - Anschutz Medical Campus, School of Medicine, Aurora, Colorado, United States of America.
- Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
- Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
- Department of Biochemistry and Molecular Genetics, University of Colorado School - Anschutz Medical Campus, School of Medicine, Aurora, Colorado, United States of America.
ORCID-Profile: Breck A Duerkop
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Science Foundation
Zitieren
APA
Andersen, S. E., Kirsch, J. M., Singh, N., Garrett, S. R., Whitney, J. C., Hesselberth, J. R., & Duerkop, B. A. (2026). Small serine recombinases are markers for antiphage defense system discovery. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003991
Vancouver
Andersen SE, Kirsch JM, Singh N, Garrett SR, Whitney JC, Hesselberth JR, et al. Small serine recombinases are markers for antiphage defense system discovery. PLOS Biology. 2026. doi:10.1371/journal.pbio.3003991
BibTeX
@article{Andersen2026,
author = {Andersen, Shelby E and Kirsch, Joshua M and Singh, Navtej and Garrett, Stephen R and Whitney, John C and Hesselberth, Jay R and Duerkop, Breck A},
title = {Small serine recombinases are markers for antiphage defense system discovery},
journal = {PLOS Biology},
year = {2026},
doi = {10.1371/journal.pbio.3003991}
}
EUVIMED